Chongqing Zhifei Biological Products (300122.SZ) Earnings Analysis
Chongqing Zhifei Biological Products (300122.SZ) next reports earnings on 2026-08-18, consensus EPS -0.05625 CNY. Last quarter (2026-04-27) it missed with EPS -0.16111 CNY vs -0.04 CNY est (-302.8%). It has beaten estimates in 0/5 recent quarters (0%). Trailing P/E -2.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300122.SZ next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | -0.05625 CNY |
| Revenue estimate | 1.94B |
300122.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | -0.16111 CNY | -0.04 CNY | -302.8% | Miss |
| 2025-10-29 | -0.25217 CNY | 0.03828 CNY | -758.8% | Miss |
| 2025-08-18 | -0.12083 CNY | 0.08549 CNY | -241.3% | Miss |
| 2024-10-25 | -0.04 CNY | 0.81 CNY | -104.9% | Miss |
| 2024-08-29 | 0.32 CNY | 0.76 CNY | -57.9% | Miss |
Beat rate: 0/5 (0%) over reported quarters with consensus data.
300122.SZ valuation and analyst view
| Trailing P/E | -2.05 |
|---|---|
| Trailing EPS | -6.18461 CNY |
| Price / book | 1.96 |
| Dividend yield | 0.00% |
| Market cap | 31.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Chongqing Zhifei Biological Products (300122.SZ)'s next earnings date?
Chongqing Zhifei Biological Products is next scheduled to report on 2026-08-18, with a consensus EPS estimate of -0.05625 CNY and revenue estimate of 1.94B.
Did 300122.SZ beat earnings last quarter?
In its 2026-04-27 report, 300122.SZ posted EPS of -0.16111 CNY versus a -0.04 CNY estimate — a miss of 302.8%.
What is 300122.SZ's earnings track record?
Over the last 5 reported quarters with consensus data, 300122.SZ beat estimates 0 times (0%).
What is 300122.SZ's current P/E ratio and EPS?
300122.SZ trades at a trailing P/E of -2.05 on trailing EPS of -6.184614498382921 CNY.
What do analysts rate 300122.SZ?
300122.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.